I had my mammogram last month. Somehow my algorithm knew that it was scheduled and I was shown a very funny comedian who was describing the entire experience like cuddling up to an aquarium-slash-panini press and assuming odd poses while hugging it and holding your breath. I have to say, I agree.
If you’re trying to understand your breast imaging and cancer screening options, here’s the bottom line up front: mammograms are the gold standard, and we strongly recommend them. They’re the only screening method proven through decades of research to actually reduce breast cancer deaths.
That said, we know some patients hesitate because of radiation concerns. So let’s talk through the full picture: what mammograms actually expose you to, and what your other options look like if you’re weighing alternatives.
Mammograms: Still the Gold Standard
Mammography has been refined since the early 1900s, with major developments in the 1960’s, 80’s, and 2000’s. A landmark 1985 study of nearly 135,000 women found screening reduced mortality by 31% and that evidence base has only grown since.
On radiation: a mammogram exposes you to about 0.28 mSv, roughly equivalent to 34 days of natural background radiation (the stuff you’re exposed to just living on Earth). For comparison, a chest X-ray is about 0.1 mSv, and a CT scan of the belly/pelvis is about 7.7 mSv. The dose is small, and the benefit of catching cancer early, is considered well worth it.
3D Mammography (Tomosynthesis/DBT): A Better Mammogram
DBT is still a mammogram, just an improved one. Instead of one flat image, it takes multiple angled X-rays and reconstructs thin slices, reducing the tissue overlap that can hide cancers or cause false alarms. It’s now the preferred standard in most clinics and has largely replaced older 2D mammography.
Breast MRI: The Most Sensitive Option
MRI is the most sensitive breast imaging tool available. It catches roughly twice as many cancers as mammography and isn’t affected by breast density. For high-risk women (like BRCA carriers), MRI-only screening starting at age 25 is already an endorsed guideline. For patients who refuse mammograms entirely, MRI is the strongest evidence-backed alternative.
The trade-offs: it requires an IV contrast dye (gadolinium), takes longer (20–40 minutes), costs more, and isn’t always covered by insurance for average-risk women. It also tends to flag more false positives, especially early on.
Contrast-Enhanced Mammography (CEM): The Rising Star
CEM combines a standard mammogram with contrast-enhanced breast imaging that shows blood flow to a lesion, similar to MRI, but using mammography equipment. It takes about 8–10 minutes, costs less than MRI, and its accuracy is now approaching MRI in several head-to-head studies.
For patients who refuse standard mammography but might accept a mammogram-like exam, CEM is a compelling option: it delivers both a mammogram-equivalent image and functional information in one visit. Downsides include a small risk of contrast reaction (under 1%) and slightly higher radiation than standard mammography.
Breast Ultrasound: A Useful Supplement, Not a Substitute
Ultrasound is radiation-free and widely available, and it’s regularly for targeted exams. But it has one major blind spot: it can’t reliably detect microcalcifications, the earliest sign of DCIS (an early, highly treatable cancer). It also produces significantly more false positives than mammography, and results vary depending on who’s performing the scan. No study has shown ultrasound alone reduces breast cancer deaths, so major guidelines don’t recommend it as a first-line screening tool.
QT Imaging: Promising, But Very Early
You may have seen local news about QT Imaging, a newer technology using sound waves from multiple angles (a bit like a CT scan, but with ultrasound). It’s radiation-free, contrast-free, and automated and it’s notably good at telling cysts from solid masses without extra workup.
However, it’s important to know: QT Imaging is FDA-cleared only as a supplement to mammograms, not a replacement as this is stated on the manufacturer’s own website. The evidence so far comes from just two small studies, both from the device maker’s own research group. In the most recent one, QT actually had lower sensitivity than 3D mammography (70.6% vs. 85.2%), and like ultrasound, it can’t detect calcifications. It’s not included in any national screening guidelines yet. It’s a technology worth watching, but not one we’d currently recommend in place of mammography.
Thermography: Not Recommended
Thermography measures heat patterns on the skin, based on the idea that tumors generate extra blood flow. Unfortunately, decades of research show wildly inconsistent results, no ability to detect calcifications, and no proof it saves lives. The FDA, ACR, and NCCN all recommend against using it as a screening or diagnostic tool.
The Bottom Line
Mammography, increasingly in its 3D form, remains the only screening tool proven to reduce breast cancer deaths, and it’s our recommendation for every patient. If radiation exposure is a genuine concern for you, breast MRI is the best-supported alternative, although it’s often out of pocket. Newer technologies like QT imaging are worth keeping an eye on, but they aren’t ready to replace proven screening yet.
If you have questions about breast imaging, we’re always happy to talk through what makes sense for your individual risk level and comfort, reach out anytime.
Follow us on Instagram to learn more from our team.
Dr. Jennifer Potter, ND
Naturopathic Doctor San Jose
408-356-1364
Dr. Jennifer Potter, ND provides natural healthcare solutions for families and individuals, focusing on perimenopause/menopause, autoimmune conditions, fatigue, and immune support. She is deeply committed to her patient’s well being, prioritizes patient education and combines natural and conventional therapies to deliver personalized care. Outside of her practice, she enjoys time with her two kids, reading fiction, and crocheting.
